Adani Group vows ₹7.5 lakh crore investment across sectors Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

$Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients$

GlobeNewswire

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

GlobeNewswire

Cell and Gene Therapy Market is expected to reach a revenue of USD 111.4 Bn by 2033, at 19.3% CAGR: Dimension Market Research

CNA

China sends largest naval fleet in decades to region, threat level severe, Taiwan says

The Times of India

This next generation GPU chip from Nvidia could boost the company's revenue by 30% and decimate competition; here's everything about the chip

La Nacion

La guerra comercial entre China y EE.UU. impactará de lleno en la producción tecnológica mundial

Richmond.com

Virginia to receive $275M federal grant to expand chip factory in Manasssas

Forbes.com.mx

Pedro Sánchez considera histórico el acuerdo UE-Mercosur, que tiende un ‘puente económico’

Investor's Business Daily

Rambus Stock Is In A Buy Zone With Its Profits Soaring

CryptoGlobe

Crypto Investment Funds Shatter Records with $3.85 Billion in Weekly Inflows, with ETH and XRP Standing Out

Storagereview.com

Google's Willow Chip Reaches Computational Capacity Milestone

CNN

Google says it has cracked a quantum computing challenge with new chip | CNN Business

The National Interest

Locked in the Skies: the Chinese and American Air Superiority Contest

The Times of India

Indian entertainment-media industry to grow 8.3% CAGR to reach Rs 3.7 trillion by 2028: PwC report

Bitcoinist

Bitcoin Price Around $200,000 “Achievable” By 2025 End, Standard Chartered Says

Bitcoinist

These 7 Cryptos Could Explode This December, Say Specialists

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma